These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 24512012)

  • 1. Sorafenib and lithium chloride combination treatment shows promising synergistic effects in human glioblastoma multiforme cells in vitro but midkine is not implicated.
    Sabancι PA; Ergüven M; Yazιhan N; Aktaş E; Aras Y; Civelek E; Aydoseli A; Imer M; Gürtekin M; Bilir A
    Neurol Res; 2014 Mar; 36(3):189-97. PubMed ID: 24512012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antagonist activity of the antipsychotic drug lithium chloride and the antileukemic drug imatinib mesylate during glioblastoma treatment in vitro.
    Aras Y; Erguven M; Aktas E; Yazihan N; Bilir A
    Neurol Res; 2016 Sep; 38(9):766-74. PubMed ID: 27367429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhancement of vinorelbine-induced cytotoxicity and apoptosis by clomipramine and lithium chloride in human neuroblastoma cancer cell line SH-SY5Y.
    Bilir A; Erguven M; Yazihan N; Aktas E; Oktem G; Sabanci A
    J Neurooncol; 2010 Dec; 100(3):385-95. PubMed ID: 20467784
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combining sorafenib with celecoxib synergistically inhibits tumor growth of non-small cell lung cancer cells in vitro and in vivo.
    Zhang H; Li Z; Wang K
    Oncol Rep; 2014 Apr; 31(4):1954-60. PubMed ID: 24549815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sorafenib inhibits cell growth but fails to enhance radio- and chemosensitivity of glioblastoma cell lines.
    Riedel M; Struve N; Müller-Goebel J; Köcher S; Petersen C; Dikomey E; Rothkamm K; Kriegs M
    Oncotarget; 2016 Sep; 7(38):61988-61995. PubMed ID: 27542273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Decreased therapeutic effects of noscapine combined with imatinib mesylate on human glioblastoma in vitro and the effect of midkine.
    Erguven M; Bilir A; Yazihan N; Ermis E; Sabanci A; Aktas E; Aras Y; Alpman V
    Cancer Cell Int; 2011 Jun; 11(1):18. PubMed ID: 21651812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PDGF receptor alpha inhibition induces apoptosis in glioblastoma cancer stem cells refractory to anti-Notch and anti-EGFR treatment.
    Cenciarelli C; Marei HE; Zonfrillo M; Pierimarchi P; Paldino E; Casalbore P; Felsani A; Vescovi AL; Maira G; Mangiola A
    Mol Cancer; 2014 Nov; 13():247. PubMed ID: 25380967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Metabolic Inhibitory Cocktail for Grave Cancers: Metformin, Pioglitazone and Lithium Combination in Treatment of Pancreatic Cancer and Glioblastoma Multiforme.
    Elmaci İ; Altinoz MA
    Biochem Genet; 2016 Oct; 54(5):573-618. PubMed ID: 27377891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiofrequency ablation suppresses distant tumour growth in a novel rat model of multifocal hepatocellular carcinoma.
    Erös de Bethlenfalva-Hora C; Mertens JC; Piguet AC; Kettenbach J; Schmitt J; Terracciano L; Weimann R; Dufour JF; Geier A
    Clin Sci (Lond); 2014 Feb; 126(3):243-52. PubMed ID: 23822114
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining celecoxib with sorafenib synergistically inhibits hepatocellular carcinoma cells in vitro.
    Morisaki T; Umebayashi M; Kiyota A; Koya N; Tanaka H; Onishi H; Katano M
    Anticancer Res; 2013 Apr; 33(4):1387-95. PubMed ID: 23564777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perifosine and sorafenib combination induces mitochondrial cell death and antitumor effects in NOD/SCID mice with Hodgkin lymphoma cell line xenografts.
    Locatelli SL; Giacomini A; Guidetti A; Cleris L; Mortarini R; Anichini A; Gianni AM; Carlo-Stella C
    Leukemia; 2013 Aug; 27(8):1677-87. PubMed ID: 23360848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-proliferative actions of N'-desmethylsorafenib in human breast cancer cells.
    Cui PH; Rawling T; Gillani TB; Bourget K; Wang XS; Zhou F; Murray M
    Biochem Pharmacol; 2013 Aug; 86(3):419-27. PubMed ID: 23732299
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synergistic anticancer activity of HS-173, a novel PI3K inhibitor in combination with Sorafenib against pancreatic cancer cells.
    Yun SM; Jung KH; Lee H; Son MK; Seo JH; Yan HH; Park BH; Hong S; Hong SS
    Cancer Lett; 2013 May; 331(2):250-61. PubMed ID: 23340175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Possible Interactions and Therapeutic Roles of Lithium Chloride and Midkine on Cancer Treatment.
    Bilir A; Aynacioglu AS; Tuna MY
    Crit Rev Oncog; 2019; 24(1):35-45. PubMed ID: 31679218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lithium increases radiosensitivity by abrogating DNA repair in breast cancer spheroid culture.
    Rouhani M; Goliaei B; Khodagholi F; Nikoofar A
    Arch Iran Med; 2014 May; 17(5):352-60. PubMed ID: 24784865
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential synergistic anti-tumor activity between lenalidomide and sorafenib in hepatocellular carcinoma.
    Ou DL; Chang CJ; Jeng YM; Lin YJ; Lin ZZ; Gandhi AK; Liao SC; Huang ZM; Hsu C; Cheng AL
    J Gastroenterol Hepatol; 2014 Dec; 29(12):2021-31. PubMed ID: 25160036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sorafenib blocks the HIF-1α/VEGFA pathway, inhibits tumor invasion, and induces apoptosis in hepatoma cells.
    Xu M; Zheng YL; Xie XY; Liang JY; Pan FS; Zheng SG; Lü MD
    DNA Cell Biol; 2014 May; 33(5):275-81. PubMed ID: 24611881
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeting FLIP and Mcl-1 using a combination of aspirin and sorafenib sensitizes colon cancer cells to TRAIL.
    Pennarun B; Kleibeuker JH; Boersma-van Ek W; Kruyt FA; Hollema H; de Vries EG; de Jong S
    J Pathol; 2013 Feb; 229(3):410-21. PubMed ID: 23132258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1082-39, an analogue of sorafenib, inhibited human cancer cell growth more potently than sorafenib.
    Chu JH; Zhao CR; Song ZY; Wang RQ; Qin YZ; Li WB; Qu XJ
    Biomed Pharmacother; 2014 Apr; 68(3):335-41. PubMed ID: 24581722
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of glioblastoma angiogenesis and invasion by combined treatments directed against vascular endothelial growth factor receptor-2, epidermal growth factor receptor, and vascular endothelial-cadherin.
    Lamszus K; Brockmann MA; Eckerich C; Bohlen P; May C; Mangold U; Fillbrandt R; Westphal M
    Clin Cancer Res; 2005 Jul; 11(13):4934-40. PubMed ID: 16000592
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.